Test Directory

Test Code
C1723
Test Name
Hereditary Hemorrhagic Telangiectasia NGS Panel
CPT Codes
81479
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of hereditary hemorrhagic telangiectasia. Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by telangiectases and arteriovenous malformations (AVMs) of the skin, mucosa and viscera. Common findings include frequent nose bleeds, gastrointestinal bleeding and telangiectases on the face, lips, tongue, fingers, and chest. AVMs can also occur within the lungs, liver, and brain, and are a significant cause of morbidity. Recommended for individuals with a personal and/or family history of hereditary hemorrhagic telangiectasia to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Alternate Names
HHT
Description

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by telangiectases and arteriovenous malformations (AVMs) of the skin, mucosa and viscera. Epistaxis is the most frequent presenting finding. Gastrointestinal bleeding and telangiectases on the face, lips, tongue, fingers, and chest are other common clinical features. AVMs within the lungs, liver, and brain are a significant cause of morbidity. Pulmonary AVMs lead to morbidity via direct hemorrhage, heart failure, or shunting of emboli with subsequent brain abscess formation or stroke. AVMs involving the liver can result in hyperdynamic circulation and cause high output heart failure. Additionally, intrahepatic arteriovenous shunts may lead to cirrhosis and resultant bleeding esophageal varices. Cerebrovascular malformations causing intracranial hemorrhage also occur. Other organs known to be affected by telangiectasia or AVMs include the bladder, eyes and kidneys.

Gene

Disorder

MIM

Inheritance

ACVRL1

Telangiectasia, hereditary hemorrhagic, type 2

600376

AD

ENG

Telangiectasia, hereditary hemorrhagic, type 1

187300

AD

GDF2

Telangiectasia, hereditary hemorrhagic, type 5

615506

AD

RASA1

Capillary malformation-arteriovenous malformation

608354

AD

SMAD4

Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome

175050

AD

Testing Schedule
Monday-Friday
Genes
ACVRL1, ENG, GDF2, RASA1, SMAD4
MIM
187300, 600376, 615506
Disease Group
Cardiovascular Disorders, Hair and Nail disorders, Skin, Tooth